Presentation is loading. Please wait.

Presentation is loading. Please wait.

Potential model of HMQ1611 inhibiting breast cancer cell proliferation

Published byJulian Simmons Modified over 5 years ago

Similar presentations

Presentation on theme: "Potential model of HMQ1611 inhibiting breast cancer cell proliferation"— Presentation transcript:

1 Potential model of HMQ1611 inhibiting breast cancer cell proliferation.
Potential model of HMQ1611 inhibiting breast cancer cell proliferation. HMQ1611 regulated ERα expression and membrane-associated E2/ERα pathway, membrane-associated E2/ERα pathway cross-talks with the MAPK pathway, in response to reduced membrane-associated ERα, MAPK activity is suppressed. Meanwhile, inhibition of EGF-induced EGFR phosphorylation by HMQ1611 blocks EGFR activation and its downstream pathways such as MAPKs and PI3K/AKT. Combined blockade of ERα and EGFR pathway leads to reduction of cell proliferation. Yingzhuan Zhan et al. Cancer Prev Res 2012;5: ©2012 by American Association for Cancer Research

Download ppt "Potential model of HMQ1611 inhibiting breast cancer cell proliferation"

Similar presentations

Estrogen & Estrogen Receptor

Estrogen & Estrogen Receptor
Figure 1. Resistance mechanism against first generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). (A) Mutations in the EGFR.

Figure 1. Resistance mechanism against first generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). (A) Mutations in the EGFR.
Odds ratios for change in PD from earliest mammogram within levels of earliest PD. No evidence for an interaction of earliest PD and change in PD on breast.

Odds ratios for change in PD from earliest mammogram within levels of earliest PD. No evidence for an interaction of earliest PD and change in PD on breast.
Targeting the PARP DNA repair pathway enhanced cytotoxicity induced by chemotherapy. Targeting the PARP DNA repair pathway enhanced cytotoxicity induced.

Targeting the PARP DNA repair pathway enhanced cytotoxicity induced by chemotherapy. Targeting the PARP DNA repair pathway enhanced cytotoxicity induced.
KG-501 suppresses NSCLC/IL-1β CM–induced migration of HUVECs by regulating IL-1β–induced CXC chemokine gene expression in NSCLC cells. KG-501 suppresses.

KG-501 suppresses NSCLC/IL-1β CM–induced migration of HUVECs by regulating IL-1β–induced CXC chemokine gene expression in NSCLC cells. KG-501 suppresses.
CDK2 is highly expressed in colon cancer cells and curcumin selectively suppresses HCT116 cell proliferation. CDK2 is highly expressed in colon cancer.

CDK2 is highly expressed in colon cancer cells and curcumin selectively suppresses HCT116 cell proliferation. CDK2 is highly expressed in colon cancer.
سرطان الثدي Breast Cancer

سرطان الثدي Breast Cancer
Figure 1 Cellular processes involved in cancer development

Figure 1 Cellular processes involved in cancer development
Inhibition of PDGFR-β downstream signaling events by flavones.

Inhibition of PDGFR-β downstream signaling events by flavones.
Fig. 2. Effects of AZD4785 on proliferation and MAPK pathway signaling in KRAS mutant and wild-type cancer cells in vitro. Effects of AZD4785 on proliferation.

Fig. 2. Effects of AZD4785 on proliferation and MAPK pathway signaling in KRAS mutant and wild-type cancer cells in vitro. Effects of AZD4785 on proliferation.
MAPK pathway inhibitors.

MAPK pathway inhibitors.
Figure 4 Possible combination therapies CDK4/6 inhibitors

Figure 4 Possible combination therapies CDK4/6 inhibitors
Figure 1 A schematic representation of the HER2 signalling pathway

Figure 1 A schematic representation of the HER2 signalling pathway
Reduction of Sca-1 increases PPARγ expression.

Reduction of Sca-1 increases PPARγ expression.
Cetuximab treatment increases IFNγ receptor 1 expression.

Cetuximab treatment increases IFNγ receptor 1 expression.
Activated membrane signaling promotes survival in response to radiation. Activated membrane signaling promotes survival in response to radiation. Radiation.

Activated membrane signaling promotes survival in response to radiation. Activated membrane signaling promotes survival in response to radiation. Radiation.
The p53 pathway is involved in the inhibition of cell proliferation observed in 15-LOX-1-overexpressing cells. The p53 pathway is involved in the inhibition.

The p53 pathway is involved in the inhibition of cell proliferation observed in 15-LOX-1-overexpressing cells. The p53 pathway is involved in the inhibition.
Friends with Benefits: Microenvironmental NRG1β and HGF Mediate HER2-Targeted Resistance in L-HER2+ and HER2E Breast Cancer  Sarah B. Crist, Cyrus M.

Friends with Benefits: Microenvironmental NRG1β and HGF Mediate HER2-Targeted Resistance in L-HER2+ and HER2E Breast Cancer  Sarah B. Crist, Cyrus M.
Schematic representation of signaling pathways modulated by PKD1 in cancer. Schematic representation of signaling pathways modulated by PKD1 in cancer.

Schematic representation of signaling pathways modulated by PKD1 in cancer. Schematic representation of signaling pathways modulated by PKD1 in cancer.
Signaling by Ras/Raf/ERK in the regulation of β-cell proliferation.

Signaling by Ras/Raf/ERK in the regulation of β-cell proliferation.

Similar presentations

Ads by Google